IL-13 R alpha 1 Overexpression Lysate (Denatured) Summary
Pasmid: pCMV-IL13RA1 full-length
IL13RA1
Packaging, Storage & Formulations
Store at -80C. Avoid freeze-thaw cycles.
Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, and 0.01% Bromophenol blue).
Lysate Details for IL-13 R alpha 1
Overexpression
Denatured
Notes
Quality control test: Transient overexpression cell lysate was tested with Anti-IL13RA1 antibody by Western Blots.
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for IL-13 R alpha 1 Overexpression Lysate (Denatured)
- bB128O4.2.1 (interleukin 13 receptor, alpha 1)
- Cancer/testis antigen 19
- CD213a1 antigen
- CD213a1
- CT19
- IL-13 R alpha 1
- IL13 receptor alpha-1 chain
- IL-13 receptor subunit alpha-1
- IL13R alpha 1
- IL-13R subunit alpha-1
- IL13R
- IL13RA
- IL-13Ra
- IL13RA1
- IL-13Ra1
- IL-13R-alpha-1
- interleukin 13 receptor, alpha 1
- interleukin-13 receptor subunit alpha-1
- NR4
Background
The protein encoded by this gene is a subunit of the interleukin 13 receptor. This subunit forms a receptor complex with IL4 receptor alpha, a subunit shared by IL13 and IL4 receptors. This subunit serves as a primary IL13-binding subunit of the IL13 receptor, and may also be a component of IL4 receptors. This protein has been shown to bind tyrosine kinase TYK2, and thus may mediate the signaling processes that lead to the activation of JAK1, STAT3 and STAT6 induced by IL13 and IL4. [provided by RefSeq]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Lysates are guaranteed for 6 months from date of receipt.
product targets :　Cell Cycle_DNA Damage inhibitors